WellnessRx Semaglutide with Vitamin B12 Injection, USP offers a dual-action, pharmacy-compounded formulation combining semaglutide—a GLP-1 receptor agonist—with energy-supporting vitamin B12. This injectable therapy is designed for adults managing obesity, weight-related comorbidities, or type 2 diabetes, under the supervision of a healthcare provider.

Semaglutide mimics the body’s natural GLP-1 hormone to slow gastric emptying, improve insulin secretion, and reduce appetite. Vitamin B12 supports red blood cell production and energy metabolism—making this formulation ideal for individuals seeking both weight loss and nutritional support.

• Compounded complex formulation of semaglutide with methylcobalamin (B12)

• Supports weight reduction through appetite suppression and delayed gastric emptying

• Improves glycemic control in patients with type 2 diabetes

• Boosts energy and combats B12 deficiency symptoms

• Convenient once-weekly subcutaneous administration

• Ideal for medically supervised weight loss programs

How It Works:

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that enhances insulin secretion and reduces hunger by acting on the brain’s appetite centers. When paired with vitamin B12, it not only helps regulate blood glucose and reduce body weight but also supports nerve function, energy production, and red blood cell formation.

Who Should Use This:

This compounded injectable is suitable for adults with a BMI ≥30, or ≥27 with weight-related conditions such as hypertension or dyslipidemia. It's also appropriate for adults with type 2 diabetes who are not achieving glycemic targets through diet and exercise alone.

Clinical Considerations:

Common side effects may include nausea, constipation, fatigue, or injection site reactions. Long-term use should be monitored for changes in renal function, thyroid markers, and B12 levels. Patients should be screened for personal or family history of medullary thyroid carcinoma (MTC) before initiating therapy.